Nucleus Genomics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Nucleus Genomics is a consumer genetic testing company based in New York City, founded in 2021. It specializes in whole-genome DNA sequencing, analyzing all 6 billion letters of a person's genome. This service provides insights into millions of genetic variants that can influence health risks, including cancers and heart disease. The whole-genome sequencing test boasts over 99.9% accuracy, offering a more comprehensive analysis compared to typical genetic tests.

In addition to sequencing services, the company partners with SteadyMD to provide genetic counseling, assisting customers in interpreting their results. Prioritizing data privacy and security, it adheres to strict healthcare standards to protect genetic information. Nucleus Genomics aims to democratize access to genetic health insights, foster diversity in genomic datasets, and build connections with underserved communities. With significant funding from notable venture capital firms, it is committed to advancing personalized healthcare through innovative genetic insights.